Literature DB >> 21078849

Granuloma formation around filarial larvae triggered by host responses to an excretory/secretory antigen.

Yashodhara Dash1, Manish Ramesh, Ramaswamy Kalyanasundaram, Gnanasekar Munirathinam, Leonard D Shultz, T V Rajan.   

Abstract

In previous studies using a murine model of filarial infection, granuloma formation was found to be a most important host-protective mechanism. We have also shown that in vitro cytoadherence is a surrogate for the formation of antifilarial granulomas in vivo and that it requires "alternatively activated" host cells and a source of antifilarial antibody. We show here that antibodies against L3 excretory/secretory (E/S) products can facilitate in vitro cytoadherence. We generated a set of hybridomas reactive with filarial E/S products and screened them for their ability to mediate in vitro cytoadherence. One clone (no. 1E9) was positive in this assay. We then screened a novel expression library of filarial antigens displayed on the surface of T7 bacteriophage for reactivity with 1E9. Phage expressing two filarial antigens (TCTP and BmALT-2) reacted with 1E9. Immunization of mice showed that the cohort immunized with BmALT-2 cleared a challenge infection with infective Brugia pahangi L3 in an accelerated manner, whereas cohorts immunized with TCTP cleared larvae with the same kinetics as in unimmunized mice. These data confirm that BmALT-2 is the antigenic target of granuloma-mediated killing of B. pahangi L3. Our findings also confirm previous studies that BmALT-2 is a potential vaccine candidate for filarial infection. Our data reinforce the work of others and also provide a possible mechanism by which immune responses to BmALT-2 may provide host protection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078849      PMCID: PMC3028858          DOI: 10.1128/IAI.00128-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  Role of natural and immune IgM antibodies in immune responses.

Authors:  M Boes
Journal:  Mol Immunol       Date:  2000-12       Impact factor: 4.407

2.  Abundant larval transcript-1 and -2 genes from Brugia malayi: diversity of genomic environments but conservation of 5' promoter sequences functional in Caenorhabditis elegans.

Authors:  Natalia Gomez-Escobar; William F Gregory; Collette Britton; Linda Murray; Craig Corton; Neil Hall; Jen Daub; Mark L Blaxter; Rick M Maizels
Journal:  Mol Biochem Parasitol       Date:  2002 Nov-Dec       Impact factor: 1.759

3.  Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.

Authors:  Uma Vanam; Vivek Pandey; Prince R Prabhu; Gajalakshmi Dakshinamurthy; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

4.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Monoclonal antibodies against urokinase.

Authors:  P Hérion; C Glineur; J D Franssen; J Urbain; A Bollen
Journal:  Biosci Rep       Date:  1981-11       Impact factor: 3.840

6.  Brugian infections in the peritoneal cavities of laboratory mice: kinetics of infection and cellular responses.

Authors:  T V Rajan; Lisa Ganley; Natalia Paciorkowski; Lisa Spencer; Thomas R Klei; Leonard D Shultz
Journal:  Exp Parasitol       Date:  2002-04       Impact factor: 2.011

7.  Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors:  Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4.

Authors:  L Spencer; L Shultz; T V Rajan
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice.

Authors:  Setty Balakrishnan Anand; Vadivel Murugan; Prince Rajaiah Prabhu; Veerabhadran Anandharaman; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Acta Trop       Date:  2008-05-01       Impact factor: 3.112

10.  Ascorbic acid is a requirement for the morphogenesis of the human filarial parasite Brugia malayi.

Authors:  T V Rajan; Natalia Paciorkowski; Ivo Kalajzic; Carol McGuiness
Journal:  J Parasitol       Date:  2003-08       Impact factor: 1.276

View more
  5 in total

Review 1.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.

Authors:  Gajalakshmi Dakshinamoorthy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

3.  Brugia pahangi: immunization with early L3 ES alters parasite migration, and reduces microfilaremia and lymphatic lesion formation in gerbils (Meriones unguiculatus).

Authors:  Ginger R Zipperer; Sridhar Arumugam; Sharon R Chirgwin; Sharon U Coleman; Krishna P Shakya; Thomas R Klei
Journal:  Exp Parasitol       Date:  2013-08-24       Impact factor: 2.011

4.  Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes.

Authors:  Simon A Babayan; Honglin Luo; Nick Gray; David W Taylor; Judith E Allen
Journal:  PLoS Negl Trop Dis       Date:  2012-12-27

5.  Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Gnanasekar Munirathinam; Kristen Stoicescu; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.